CervoMed Inc. short interest in 2021
In 2021, CervoMed Inc.'s disclosed short interest ran from 1.13% of shares outstanding on 15 Jan 2021 to 1.06% on 31 Dec 2021, a change of -0.07 percentage points. The year's high was 2.75% on 15 Apr 2021 and its low 0.45% on 30 Nov 2021, averaging 1.28% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.06 days on 15 Apr 2021. Full history: CervoMed Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 1.13% (15 Jan 2021)
- End of year
- 1.06% (31 Dec 2021)
- Change
- -0.07 pp
- High
- 2.75% (15 Apr 2021)
- Low
- 0.45% (30 Nov 2021)
- Average
- 1.28%
- Highest days to cover
- 2.06 (15 Apr 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 1.13% | 1.00 | |
| 29 Jan 2021 | 1.19% | 1.00 | |
| 12 Feb 2021 | 0.81% | 1.00 | |
| 15 Mar 2021 | 2.19% | 1.00 | |
| 31 Mar 2021 | 2.56% | 1.00 | 10-K filed, results (8-K) |
| 15 Apr 2021 | 2.75% | 2.06 | |
| 30 Apr 2021 | 2.18% | 1.92 | |
| 14 May 2021 | 1.56% | 1.00 | 10-Q filed, results (8-K) |
| 28 May 2021 | 1.25% | 1.00 | |
| 15 Jun 2021 | 0.99% | 1.00 | |
| 30 Jun 2021 | 1.04% | 1.00 | |
| 15 Jul 2021 | 1.71% | 1.00 | |
| 30 Jul 2021 | 1.63% | 1.22 | |
| 13 Aug 2021 | 1.33% | 1.01 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 0.97% | 1.00 | |
| 15 Sep 2021 | 0.97% | 1.00 | |
| 30 Sep 2021 | 0.77% | 1.10 | |
| 15 Oct 2021 | 0.60% | 1.00 | |
| 29 Oct 2021 | 0.71% | 1.00 | |
| 15 Nov 2021 | 0.56% | 1.00 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 0.45% | 1.00 | |
| 15 Dec 2021 | 0.93% | 1.00 | |
| 31 Dec 2021 | 1.06% | 1.00 |
See also: CervoMed Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.